CSL Ltd Stock
Price
Target price
€83.88
€83.88
-0.840%
-0.71
-0.840%
-
02.04.26 / Tradegate
WKN: 890952 / Symbol: CMXHF / Name: CSL / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
CSL Ltd Stock
CSL Ltd shows a slight decrease today, losing -€0.710 (-0.840%) compared to yesterday.
Pros and Cons of CSL Ltd in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of CSL Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| CSL Ltd | -0.840% | 1.969% | -7.079% | -43.132% | -15.478% | -52.945% | -50.873% |
| Grifols S.A. | -1.200% | 6.437% | -12.514% | 6.876% | -14.636% | 1.194% | -58.989% |
| Incyte Corp. | -0.420% | 1.877% | -4.862% | 41.713% | -3.348% | 22.112% | 15.494% |
| IQVIA Holdings Inc. | -1.440% | 2.177% | 0.738% | -6.534% | -22.216% | -18.022% | -10.702% |
News
Carlisle Companies: A Strong Contender in the Building Products Sector
Explore the exciting world of Carlisle Companies (NYSE: CSL) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into
This Growth Stock Is Building Its Case to Smart Investors
There's a boom going on in much of the U.S., and it's not just tied to technology. Housing shortages have spurred residential homebuilding activity, particularly in fast-growing areas like the Sun
Flu Season's Here—This Dividend-Payer Controls the Shot Market
Last year wasn’t kind to the health care sector. That corner of the market, which includes Big Pharma mainstays such as Eli Lilly (NYSE: LLY), Johnson & Johnson (NYSE: JNJ), and AbbVie (NYSE:
